EVA CLARK to Trypanosoma cruzi
This is a "connection" page, showing publications EVA CLARK has written about Trypanosoma cruzi.
Connection Strength
3.118
-
Chronic Chagas Disease in the US. JAMA. 2024 06 18; 331(23):2037-2038.
Score: 0.693
-
Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States. Clin Infect Dis. 2024 02 17; 78(2):453-456.
Score: 0.677
-
Screening for Chagas Disease Should Be Included in Entry-to-Care Testing for At-Risk People With Human Immunodeficiency Virus (HIV) Living in the United States. Clin Infect Dis. 2022 09 14; 75(5):901-906.
Score: 0.613
-
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. J Clin Invest. 2026 Mar 16; 136(6).
Score: 0.194
-
Screening for Trypanosoma cruzi in patients living with the human immunodeficiency virus (PWH) in the Peruvian Amazon. Travel Med Infect Dis. 2025 Nov-Dec; 68:102927.
Score: 0.190
-
Chagas disease in the immunocompromised host. Curr Opin Infect Dis. 2024 Oct 01; 37(5):333-341.
Score: 0.174
-
Chagas disease in immunocompromised patients. Clin Microbiol Rev. 2024 Jun 13; 37(2):e0009923.
Score: 0.170
-
Chagas Disease Diagnostic Practices at Four Major Hospital Systems in California and Texas. J Infect Dis. 2024 01 12; 229(1):198-202.
Score: 0.168
-
Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States. Emerg Infect Dis. 2022 07; 28(7):1313-1320.
Score: 0.151
-
Field evaluation of the InBios Chagas detect plus rapid test in serum and whole-blood specimens in Bolivia. Clin Vaccine Immunol. 2014 Dec; 21(12):1645-9.
Score: 0.088